SQI Diagnostics Inc. is a listed company. Filings by its managers are published through SEDI. Over the twelve months to 18 October 2026, 4 filings were filed, from 2 insiders.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Compared with its exchange (2,134 companies, median 12 filings), a count of 4 filings is below the norm.
No insider has bought SQI Diagnostics Inc. shares on the open market in the past twelve months. Filings reach the SEDI feed a median of 30 days after the trade. Until a filing is published, the market cannot know about the trade.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
· cache
4 of 4 declarations
SQI Diagnostics Inc. is a company focused on developing diagnostic tests for clinical applications. It is listed on the XTSE.